Yüklüyor......
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: a single centre analysis of toxicity and clinical outcome
OBJECTIVES: The current standard of care for patients with metastatic prostate cancer (mPCa) at diagnosis is androgen deprivation therapy (ADT) with or without anti-androgen and chemotherapy. The aim of this study was to define the role of a local radiotherapy (RT) treatment in the mPCa setting. MET...
Kaydedildi:
| Yayımlandı: | Ecancermedicalscience |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Cancer Intelligence
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5718249/ https://ncbi.nlm.nih.gov/pubmed/29225693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2017.786 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|